Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U

Eur J Pharmacol, (3):303-314 1970

MED: 5477307

Evidence for dopamine receptor stimulation by apomorphine.

Anden NE, Rubenson A, Fuxe K, Hokfelt T

J Pharm Pharmacol, (9):627-629 1967

MED: 4383150

Central catecholamine turnover and self-stimulation behaviour.

Arbuthnott G, Fuxe K, Ungerstedt U

Brain Res, (2):406-413 1971

MED: 5552182

Differential self-injection behavior produced by fenfluramine versus other appetite-inhibiting drugs

Baxter

1973

Apomorphine in Parkinsonian tremor.

Braham J, Sarova-Pinhas I, Goldhammer Y

Br Med J, (5725):768 1970

MED: 5472764

Amphetamine and brain catecholamines

Carlsson

1970

On the mode of action of apomorphine.

Costall B, Naylor RJ

Eur J Pharmacol, (3):350-361 1973

MED: 4708071

Similarities between neurologic effects of L-dopa and of apomorphine.

Cotzias GC, Papavasiliou PS, Fehling C, Kaufman B, Mena I

N Engl J Med, (1):31-33 1970

MED: 4901383

A map of the rat mesencephalon for electrical self-stimulation.

Crow TJ

Brain Res, (2):265-273 1972

MED: 5009639

Injected apomorphine and orally administered levodopa in Parkinsonism.

Duby SE, Cotzias GC, Papavasiliou PS, Lawrence WH

Arch Neurol, (6):474-480 1972

MED: 4563448